nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—hematologic cancer	0.574	1	CbGaD
Cefdinir—MPO—Cisplatin—hematologic cancer	0.0364	1	CbGbCtD
Cefdinir—MPO—C-MYB transcription factor network—TOM1—hematologic cancer	0.00247	0.0484	CbGpPWpGaD
Cefdinir—SLC22A5—Organic cation transport—SLC22A1—hematologic cancer	0.00237	0.0464	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PAX5—hematologic cancer	0.00187	0.0367	CbGpPWpGaD
Cefdinir—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A1—hematologic cancer	0.00161	0.0315	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—LYZ—hematologic cancer	0.00159	0.0312	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PRTN3—hematologic cancer	0.00142	0.0278	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—ANPEP—hematologic cancer	0.00121	0.0237	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—SPI1—hematologic cancer	0.00108	0.0211	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MAF—hematologic cancer	0.00108	0.0211	CbGpPWpGaD
Cefdinir—Cefazolin—PON1—hematologic cancer	0.00101	0.556	CrCbGaD
Cefdinir—MPO—Selenium Micronutrient Network—PRDX2—hematologic cancer	0.000882	0.0173	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GATA1—hematologic cancer	0.000816	0.016	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CSF1—hematologic cancer	0.000723	0.0142	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTR—hematologic cancer	0.000717	0.014	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—LEF1—hematologic cancer	0.000706	0.0138	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CEBPD—hematologic cancer	0.000694	0.0136	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CEBPA—hematologic cancer	0.000694	0.0136	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CSF1R—hematologic cancer	0.000694	0.0136	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT1—hematologic cancer	0.000664	0.013	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT5A—hematologic cancer	0.000597	0.0117	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTR—hematologic cancer	0.000583	0.0114	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TXN—hematologic cancer	0.000568	0.0111	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CD34—hematologic cancer	0.000565	0.0111	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—BIRC3—hematologic cancer	0.000544	0.0107	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYB—hematologic cancer	0.000544	0.0107	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.000543	0.0106	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALOX5—hematologic cancer	0.000506	0.00992	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.000504	0.00987	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTR—hematologic cancer	0.000463	0.00907	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD2—hematologic cancer	0.000436	0.00854	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NFKBIA—hematologic cancer	0.00043	0.00843	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GATA3—hematologic cancer	0.00042	0.00823	CbGpPWpGaD
Cefdinir—Cefaclor—MPO—hematologic cancer	0.00041	0.225	CrCbGaD
Cefdinir—MPO—C-MYB transcription factor network—CDK6—hematologic cancer	0.000398	0.0078	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CCL2—hematologic cancer	0.000388	0.0076	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTHFR—hematologic cancer	0.000384	0.00752	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—hematologic cancer	0.000365	0.00715	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SOD2—hematologic cancer	0.000355	0.00695	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3R1—hematologic cancer	0.000346	0.00678	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL4—hematologic cancer	0.000344	0.00673	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—JAK2—hematologic cancer	0.000336	0.00659	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ICAM1—hematologic cancer	0.000336	0.00657	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—hematologic cancer	0.00033	0.00647	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000322	0.00631	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CD4—hematologic cancer	0.000319	0.00624	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KITLG—hematologic cancer	0.000317	0.00621	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTHFR—hematologic cancer	0.000312	0.00612	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CCL2—hematologic cancer	0.0003	0.00588	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CRP—hematologic cancer	0.000297	0.00582	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—hematologic cancer	0.000294	0.00577	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL2—hematologic cancer	0.000293	0.00575	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—HES1—hematologic cancer	0.000293	0.00574	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—hematologic cancer	0.000291	0.00571	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—NCOR1—hematologic cancer	0.000291	0.00571	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SOD2—hematologic cancer	0.000282	0.00552	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—hematologic cancer	0.00028	0.00548	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ICAM1—hematologic cancer	0.000273	0.00535	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000272	0.00533	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—hematologic cancer	0.000255	0.005	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000252	0.00495	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000248	0.00486	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTHFR—hematologic cancer	0.000248	0.00486	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—hematologic cancer	0.000247	0.00483	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CCL2—hematologic cancer	0.000244	0.00479	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000242	0.00475	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—hematologic cancer	0.000236	0.00462	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—hematologic cancer	0.000228	0.00446	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—hematologic cancer	0.000228	0.00446	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000225	0.00441	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000221	0.00434	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ICAM1—hematologic cancer	0.000217	0.00425	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KIT—hematologic cancer	0.000216	0.00424	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—hematologic cancer	0.000214	0.00418	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IFNG—hematologic cancer	0.000208	0.00407	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CREBBP—hematologic cancer	0.000201	0.00393	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000196	0.00384	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3CA—hematologic cancer	0.000195	0.00381	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CCL2—hematologic cancer	0.000194	0.0038	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL1B—hematologic cancer	0.000185	0.00363	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL2—hematologic cancer	0.000185	0.00362	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000182	0.00357	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000182	0.00357	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—hematologic cancer	0.000181	0.00354	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000179	0.00351	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN2A—hematologic cancer	0.000176	0.00344	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—hematologic cancer	0.000173	0.00339	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—hematologic cancer	0.000172	0.00338	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000169	0.00332	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000166	0.00326	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CD4—hematologic cancer	0.000165	0.00324	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—hematologic cancer	0.000165	0.00324	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—hematologic cancer	0.000165	0.00323	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.00016	0.00314	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1B—hematologic cancer	0.000156	0.00305	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000151	0.00296	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000149	0.00292	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000149	0.00291	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CCND1—hematologic cancer	0.000148	0.00291	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—hematologic cancer	0.000147	0.00288	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000146	0.00287	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000146	0.00286	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1A—hematologic cancer	0.000144	0.00281	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.00014	0.00275	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000138	0.00271	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000138	0.00271	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000138	0.0027	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—EP300—hematologic cancer	0.000137	0.00268	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000136	0.00266	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000135	0.00265	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—hematologic cancer	0.000134	0.00263	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—hematologic cancer	0.000133	0.00261	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000133	0.00261	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.00013	0.00255	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000128	0.00251	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—NRAS—hematologic cancer	0.000128	0.0025	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000126	0.00247	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000123	0.00241	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000121	0.00236	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYC—hematologic cancer	0.000119	0.00233	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000119	0.00232	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—hematologic cancer	0.000119	0.00232	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000114	0.00224	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000113	0.00221	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000113	0.00221	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000113	0.00221	CbGpPWpGaD
Cefdinir—Cefazolin—ALB—hematologic cancer	0.000113	0.0619	CrCbGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000112	0.0022	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KRAS—hematologic cancer	0.00011	0.00215	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—hematologic cancer	0.000108	0.00213	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—hematologic cancer	0.000107	0.00209	CbGpPWpGaD
Cefdinir—Ceftriaxone—ALB—hematologic cancer	0.000107	0.0587	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000105	0.00205	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000105	0.00205	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000105	0.00205	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000103	0.00202	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000103	0.00202	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000103	0.00202	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000101	0.00199	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	9.42e-05	0.00184	CbGpPWpGaD
Cefdinir—Cefalotin—ALB—hematologic cancer	9.35e-05	0.0514	CrCbGaD
Cefdinir—MPO—C-MYB transcription factor network—HRAS—hematologic cancer	9.35e-05	0.00183	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	9.26e-05	0.00181	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	8.91e-05	0.00175	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—hematologic cancer	8.62e-05	0.00169	CbGpPWpGaD
Cefdinir—Cephalexin—ALB—hematologic cancer	8.5e-05	0.0467	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	8.27e-05	0.00162	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.15e-05	0.0016	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCC3—hematologic cancer	8.13e-05	0.00159	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.69e-05	0.00151	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	7.56e-05	0.00148	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.47e-05	0.00146	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	7.44e-05	0.00146	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.41e-05	0.00145	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.26e-05	0.00142	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.14e-05	0.0014	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.02e-05	0.00138	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.93e-05	0.00136	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.88e-05	0.00135	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.81e-05	0.00133	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.77e-05	0.00133	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.74e-05	0.00132	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.63e-05	0.0013	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.47e-05	0.00127	CbGpPWpGaD
Cefdinir—Haemorrhage—Methotrexate—hematologic cancer	6.03e-05	0.000179	CcSEcCtD
Cefdinir—Asthenia—Gemcitabine—hematologic cancer	6.01e-05	0.000178	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.01e-05	0.00118	CbGpPWpGaD
Cefdinir—Haematuria—Epirubicin—hematologic cancer	6e-05	0.000178	CcSEcCtD
Cefdinir—Dizziness—Ifosfamide—hematologic cancer	5.99e-05	0.000178	CcSEcCtD
Cefdinir—Pruritus—Gemcitabine—hematologic cancer	5.93e-05	0.000176	CcSEcCtD
Cefdinir—Nausea—Thiotepa—hematologic cancer	5.92e-05	0.000176	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.91e-05	0.00116	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Betamethasone—hematologic cancer	5.89e-05	0.000175	CcSEcCtD
Cefdinir—Anaphylactic shock—Dexamethasone—hematologic cancer	5.89e-05	0.000175	CcSEcCtD
Cefdinir—Diarrhoea—Mitoxantrone—hematologic cancer	5.89e-05	0.000175	CcSEcCtD
Cefdinir—Diarrhoea—Irinotecan—hematologic cancer	5.89e-05	0.000175	CcSEcCtD
Cefdinir—Vomiting—Carmustine—hematologic cancer	5.88e-05	0.000175	CcSEcCtD
Cefdinir—Insomnia—Triamcinolone—hematologic cancer	5.87e-05	0.000174	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—hematologic cancer	5.87e-05	0.000174	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—hematologic cancer	5.85e-05	0.000174	CcSEcCtD
Cefdinir—Gastrointestinal pain—Etoposide—hematologic cancer	5.85e-05	0.000174	CcSEcCtD
Cefdinir—Dizziness—Vincristine—hematologic cancer	5.84e-05	0.000173	CcSEcCtD
Cefdinir—Rash—Carmustine—hematologic cancer	5.83e-05	0.000173	CcSEcCtD
Cefdinir—Dermatitis—Carmustine—hematologic cancer	5.83e-05	0.000173	CcSEcCtD
Cefdinir—Vomiting—Alitretinoin—hematologic cancer	5.83e-05	0.000173	CcSEcCtD
Cefdinir—Headache—Carmustine—hematologic cancer	5.8e-05	0.000172	CcSEcCtD
Cefdinir—Shock—Betamethasone—hematologic cancer	5.79e-05	0.000172	CcSEcCtD
Cefdinir—Shock—Dexamethasone—hematologic cancer	5.79e-05	0.000172	CcSEcCtD
Cefdinir—Rash—Alitretinoin—hematologic cancer	5.78e-05	0.000172	CcSEcCtD
Cefdinir—Agitation—Prednisone—hematologic cancer	5.77e-05	0.000171	CcSEcCtD
Cefdinir—Dermatitis—Alitretinoin—hematologic cancer	5.77e-05	0.000171	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.77e-05	0.000171	CcSEcCtD
Cefdinir—Thrombocytopenia—Dexamethasone—hematologic cancer	5.77e-05	0.000171	CcSEcCtD
Cefdinir—Thrombocytopenia—Betamethasone—hematologic cancer	5.77e-05	0.000171	CcSEcCtD
Cefdinir—Vomiting—Ifosfamide—hematologic cancer	5.76e-05	0.000171	CcSEcCtD
Cefdinir—Hypersensitivity—Cisplatin—hematologic cancer	5.75e-05	0.000171	CcSEcCtD
Cefdinir—Headache—Alitretinoin—hematologic cancer	5.74e-05	0.00017	CcSEcCtD
Cefdinir—Diarrhoea—Gemcitabine—hematologic cancer	5.73e-05	0.00017	CcSEcCtD
Cefdinir—Nausea—Thalidomide—hematologic cancer	5.72e-05	0.00017	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—hematologic cancer	5.72e-05	0.00017	CcSEcCtD
Cefdinir—Dyspepsia—Triamcinolone—hematologic cancer	5.71e-05	0.00017	CcSEcCtD
Cefdinir—Rash—Ifosfamide—hematologic cancer	5.71e-05	0.00017	CcSEcCtD
Cefdinir—Dermatitis—Ifosfamide—hematologic cancer	5.71e-05	0.000169	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—hematologic cancer	5.7e-05	0.000169	CcSEcCtD
Cefdinir—Dizziness—Irinotecan—hematologic cancer	5.69e-05	0.000169	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—hematologic cancer	5.67e-05	0.000168	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—hematologic cancer	5.67e-05	0.000168	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—hematologic cancer	5.67e-05	0.000168	CcSEcCtD
Cefdinir—Body temperature increased—Etoposide—hematologic cancer	5.66e-05	0.000168	CcSEcCtD
Cefdinir—Abdominal pain—Etoposide—hematologic cancer	5.66e-05	0.000168	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—hematologic cancer	5.66e-05	0.000168	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—hematologic cancer	5.65e-05	0.000168	CcSEcCtD
Cefdinir—Vomiting—Vincristine—hematologic cancer	5.62e-05	0.000167	CcSEcCtD
Cefdinir—Anorexia—Betamethasone—hematologic cancer	5.61e-05	0.000167	CcSEcCtD
Cefdinir—Anorexia—Dexamethasone—hematologic cancer	5.61e-05	0.000167	CcSEcCtD
Cefdinir—Asthenia—Cisplatin—hematologic cancer	5.6e-05	0.000166	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.58e-05	0.00109	CbGpPWpGaD
Cefdinir—Rash—Vincristine—hematologic cancer	5.57e-05	0.000165	CcSEcCtD
Cefdinir—Dermatitis—Vincristine—hematologic cancer	5.56e-05	0.000165	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—hematologic cancer	5.55e-05	0.000165	CcSEcCtD
Cefdinir—Headache—Vincristine—hematologic cancer	5.53e-05	0.000164	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisone—hematologic cancer	5.52e-05	0.000164	CcSEcCtD
Cefdinir—Nausea—Carmustine—hematologic cancer	5.5e-05	0.000163	CcSEcCtD
Cefdinir—Vomiting—Mitoxantrone—hematologic cancer	5.47e-05	0.000162	CcSEcCtD
Cefdinir—Vomiting—Irinotecan—hematologic cancer	5.47e-05	0.000162	CcSEcCtD
Cefdinir—Nausea—Alitretinoin—hematologic cancer	5.45e-05	0.000162	CcSEcCtD
Cefdinir—Convulsion—Prednisone—hematologic cancer	5.44e-05	0.000162	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.43e-05	0.00106	CbGpPWpGaD
Cefdinir—Agranulocytosis—Doxorubicin—hematologic cancer	5.43e-05	0.000161	CcSEcCtD
Cefdinir—Hypertension—Prednisone—hematologic cancer	5.43e-05	0.000161	CcSEcCtD
Cefdinir—Rash—Mitoxantrone—hematologic cancer	5.42e-05	0.000161	CcSEcCtD
Cefdinir—Rash—Irinotecan—hematologic cancer	5.42e-05	0.000161	CcSEcCtD
Cefdinir—Dermatitis—Irinotecan—hematologic cancer	5.42e-05	0.000161	CcSEcCtD
Cefdinir—Dermatitis—Mitoxantrone—hematologic cancer	5.42e-05	0.000161	CcSEcCtD
Cefdinir—Headache—Irinotecan—hematologic cancer	5.39e-05	0.00016	CcSEcCtD
Cefdinir—Headache—Mitoxantrone—hematologic cancer	5.39e-05	0.00016	CcSEcCtD
Cefdinir—Nausea—Ifosfamide—hematologic cancer	5.38e-05	0.00016	CcSEcCtD
Cefdinir—Diarrhoea—Cisplatin—hematologic cancer	5.34e-05	0.000159	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—hematologic cancer	5.34e-05	0.000158	CcSEcCtD
Cefdinir—Vomiting—Gemcitabine—hematologic cancer	5.33e-05	0.000158	CcSEcCtD
Cefdinir—Insomnia—Betamethasone—hematologic cancer	5.33e-05	0.000158	CcSEcCtD
Cefdinir—Insomnia—Dexamethasone—hematologic cancer	5.33e-05	0.000158	CcSEcCtD
Cefdinir—Rash—Gemcitabine—hematologic cancer	5.28e-05	0.000157	CcSEcCtD
Cefdinir—Dermatitis—Gemcitabine—hematologic cancer	5.28e-05	0.000157	CcSEcCtD
Cefdinir—Hypersensitivity—Etoposide—hematologic cancer	5.27e-05	0.000156	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—hematologic cancer	5.25e-05	0.000156	CcSEcCtD
Cefdinir—Headache—Gemcitabine—hematologic cancer	5.25e-05	0.000156	CcSEcCtD
Cefdinir—Nausea—Vincristine—hematologic cancer	5.25e-05	0.000156	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—hematologic cancer	5.22e-05	0.000155	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisolone—hematologic cancer	5.2e-05	0.000154	CcSEcCtD
Cefdinir—Dyspepsia—Dexamethasone—hematologic cancer	5.18e-05	0.000154	CcSEcCtD
Cefdinir—Dyspepsia—Betamethasone—hematologic cancer	5.18e-05	0.000154	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.18e-05	0.00101	CbGpPWpGaD
Cefdinir—Asthenia—Etoposide—hematologic cancer	5.13e-05	0.000152	CcSEcCtD
Cefdinir—Body temperature increased—Triamcinolone—hematologic cancer	5.13e-05	0.000152	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisone—hematologic cancer	5.13e-05	0.000152	CcSEcCtD
Cefdinir—Decreased appetite—Dexamethasone—hematologic cancer	5.12e-05	0.000152	CcSEcCtD
Cefdinir—Decreased appetite—Betamethasone—hematologic cancer	5.12e-05	0.000152	CcSEcCtD
Cefdinir—Nausea—Irinotecan—hematologic cancer	5.11e-05	0.000152	CcSEcCtD
Cefdinir—Nausea—Mitoxantrone—hematologic cancer	5.11e-05	0.000152	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.09e-05	0.000998	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.08e-05	0.000151	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.08e-05	0.000151	CcSEcCtD
Cefdinir—Pruritus—Etoposide—hematologic cancer	5.06e-05	0.00015	CcSEcCtD
Cefdinir—Shock—Prednisone—hematologic cancer	5.05e-05	0.00015	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.04e-05	0.000988	CbGpPWpGaD
Cefdinir—Nausea—Gemcitabine—hematologic cancer	4.98e-05	0.000148	CcSEcCtD
Cefdinir—Vomiting—Cisplatin—hematologic cancer	4.97e-05	0.000147	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.96e-05	0.000971	CbGpPWpGaD
Cefdinir—Erythema multiforme—Doxorubicin—hematologic cancer	4.94e-05	0.000147	CcSEcCtD
Cefdinir—Rash—Cisplatin—hematologic cancer	4.92e-05	0.000146	CcSEcCtD
Cefdinir—Dermatitis—Cisplatin—hematologic cancer	4.92e-05	0.000146	CcSEcCtD
Cefdinir—Diarrhoea—Etoposide—hematologic cancer	4.9e-05	0.000145	CcSEcCtD
Cefdinir—Anorexia—Prednisone—hematologic cancer	4.89e-05	0.000145	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—hematologic cancer	4.84e-05	0.000144	CcSEcCtD
Cefdinir—Gastrointestinal pain—Betamethasone—hematologic cancer	4.82e-05	0.000143	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.82e-05	0.000143	CcSEcCtD
Cefdinir—Hypersensitivity—Triamcinolone—hematologic cancer	4.78e-05	0.000142	CcSEcCtD
Cefdinir—Dizziness—Etoposide—hematologic cancer	4.73e-05	0.00014	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—hematologic cancer	4.7e-05	0.00014	CcSEcCtD
Cefdinir—Dizziness—Prednisolone—hematologic cancer	4.67e-05	0.000139	CcSEcCtD
Cefdinir—Asthenia—Triamcinolone—hematologic cancer	4.66e-05	0.000138	CcSEcCtD
Cefdinir—Abdominal pain—Betamethasone—hematologic cancer	4.66e-05	0.000138	CcSEcCtD
Cefdinir—Abdominal pain—Dexamethasone—hematologic cancer	4.66e-05	0.000138	CcSEcCtD
Cefdinir—Body temperature increased—Betamethasone—hematologic cancer	4.66e-05	0.000138	CcSEcCtD
Cefdinir—Body temperature increased—Dexamethasone—hematologic cancer	4.66e-05	0.000138	CcSEcCtD
Cefdinir—Nausea—Cisplatin—hematologic cancer	4.64e-05	0.000138	CcSEcCtD
Cefdinir—Insomnia—Prednisone—hematologic cancer	4.64e-05	0.000138	CcSEcCtD
Cefdinir—Pruritus—Triamcinolone—hematologic cancer	4.59e-05	0.000136	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—hematologic cancer	4.55e-05	0.000135	CcSEcCtD
Cefdinir—Vomiting—Etoposide—hematologic cancer	4.55e-05	0.000135	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.53e-05	0.000888	CbGpPWpGaD
Cefdinir—Agitation—Epirubicin—hematologic cancer	4.52e-05	0.000134	CcSEcCtD
Cefdinir—Dyspepsia—Prednisone—hematologic cancer	4.51e-05	0.000134	CcSEcCtD
Cefdinir—Rash—Etoposide—hematologic cancer	4.51e-05	0.000134	CcSEcCtD
Cefdinir—Dermatitis—Etoposide—hematologic cancer	4.51e-05	0.000134	CcSEcCtD
Cefdinir—Headache—Etoposide—hematologic cancer	4.48e-05	0.000133	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—hematologic cancer	4.48e-05	0.000133	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—hematologic cancer	4.47e-05	0.000133	CcSEcCtD
Cefdinir—Decreased appetite—Prednisone—hematologic cancer	4.46e-05	0.000132	CcSEcCtD
Cefdinir—Rash—Prednisolone—hematologic cancer	4.45e-05	0.000132	CcSEcCtD
Cefdinir—Dermatitis—Prednisolone—hematologic cancer	4.45e-05	0.000132	CcSEcCtD
Cefdinir—Headache—Prednisolone—hematologic cancer	4.42e-05	0.000131	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—hematologic cancer	4.4e-05	0.000131	CcSEcCtD
Cefdinir—Constipation—Prednisone—hematologic cancer	4.39e-05	0.00013	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—hematologic cancer	4.32e-05	0.000128	CcSEcCtD
Cefdinir—Dizziness—Triamcinolone—hematologic cancer	4.29e-05	0.000127	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—hematologic cancer	4.29e-05	0.000127	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—hematologic cancer	4.26e-05	0.000126	CcSEcCtD
Cefdinir—Nausea—Etoposide—hematologic cancer	4.25e-05	0.000126	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—hematologic cancer	4.24e-05	0.000126	CcSEcCtD
Cefdinir—Asthenia—Dexamethasone—hematologic cancer	4.23e-05	0.000125	CcSEcCtD
Cefdinir—Asthenia—Betamethasone—hematologic cancer	4.23e-05	0.000125	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.21e-05	0.000824	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Methotrexate—hematologic cancer	4.2e-05	0.000125	CcSEcCtD
Cefdinir—Gastrointestinal pain—Prednisone—hematologic cancer	4.19e-05	0.000124	CcSEcCtD
Cefdinir—Nausea—Prednisolone—hematologic cancer	4.19e-05	0.000124	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—hematologic cancer	4.18e-05	0.000124	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—hematologic cancer	4.18e-05	0.000124	CcSEcCtD
Cefdinir—Pruritus—Dexamethasone—hematologic cancer	4.17e-05	0.000124	CcSEcCtD
Cefdinir—Pruritus—Betamethasone—hematologic cancer	4.17e-05	0.000124	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.14e-05	0.00081	CbGpPWpGaD
Cefdinir—Vomiting—Triamcinolone—hematologic cancer	4.13e-05	0.000122	CcSEcCtD
Cefdinir—Rash—Triamcinolone—hematologic cancer	4.09e-05	0.000121	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—hematologic cancer	4.09e-05	0.000121	CcSEcCtD
Cefdinir—Dermatitis—Triamcinolone—hematologic cancer	4.09e-05	0.000121	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—hematologic cancer	4.09e-05	0.000121	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—hematologic cancer	4.07e-05	0.000121	CcSEcCtD
Cefdinir—Headache—Triamcinolone—hematologic cancer	4.07e-05	0.000121	CcSEcCtD
Cefdinir—Body temperature increased—Prednisone—hematologic cancer	4.05e-05	0.00012	CcSEcCtD
Cefdinir—Abdominal pain—Prednisone—hematologic cancer	4.05e-05	0.00012	CcSEcCtD
Cefdinir—Diarrhoea—Betamethasone—hematologic cancer	4.03e-05	0.00012	CcSEcCtD
Cefdinir—Diarrhoea—Dexamethasone—hematologic cancer	4.03e-05	0.00012	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—hematologic cancer	4.01e-05	0.000119	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—hematologic cancer	4e-05	0.000119	CcSEcCtD
Cefdinir—Shock—Epirubicin—hematologic cancer	3.95e-05	0.000117	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—hematologic cancer	3.94e-05	0.000117	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—hematologic cancer	3.93e-05	0.000117	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—hematologic cancer	3.93e-05	0.000117	CcSEcCtD
Cefdinir—Dizziness—Dexamethasone—hematologic cancer	3.89e-05	0.000116	CcSEcCtD
Cefdinir—Dizziness—Betamethasone—hematologic cancer	3.89e-05	0.000116	CcSEcCtD
Cefdinir—Insomnia—Methotrexate—hematologic cancer	3.88e-05	0.000115	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—hematologic cancer	3.87e-05	0.000115	CcSEcCtD
Cefdinir—Nausea—Triamcinolone—hematologic cancer	3.86e-05	0.000114	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—hematologic cancer	3.82e-05	0.000113	CcSEcCtD
Cefdinir—Somnolence—Methotrexate—hematologic cancer	3.81e-05	0.000113	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—hematologic cancer	3.79e-05	0.000112	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisone—hematologic cancer	3.78e-05	0.000112	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—hematologic cancer	3.77e-05	0.000112	CcSEcCtD
Cefdinir—Vomiting—Dexamethasone—hematologic cancer	3.74e-05	0.000111	CcSEcCtD
Cefdinir—Vomiting—Betamethasone—hematologic cancer	3.74e-05	0.000111	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—hematologic cancer	3.73e-05	0.000111	CcSEcCtD
Cefdinir—Rash—Betamethasone—hematologic cancer	3.71e-05	0.00011	CcSEcCtD
Cefdinir—Rash—Dexamethasone—hematologic cancer	3.71e-05	0.00011	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—hematologic cancer	3.71e-05	0.00011	CcSEcCtD
Cefdinir—Dermatitis—Betamethasone—hematologic cancer	3.71e-05	0.00011	CcSEcCtD
Cefdinir—Dermatitis—Dexamethasone—hematologic cancer	3.71e-05	0.00011	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.7e-05	0.00011	CcSEcCtD
Cefdinir—Headache—Dexamethasone—hematologic cancer	3.69e-05	0.00011	CcSEcCtD
Cefdinir—Headache—Betamethasone—hematologic cancer	3.69e-05	0.00011	CcSEcCtD
Cefdinir—Asthenia—Prednisone—hematologic cancer	3.68e-05	0.000109	CcSEcCtD
Cefdinir—Shock—Doxorubicin—hematologic cancer	3.65e-05	0.000108	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—hematologic cancer	3.63e-05	0.000108	CcSEcCtD
Cefdinir—Pruritus—Prednisone—hematologic cancer	3.63e-05	0.000108	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—hematologic cancer	3.63e-05	0.000108	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—hematologic cancer	3.57e-05	0.000106	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—hematologic cancer	3.54e-05	0.000105	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—hematologic cancer	3.53e-05	0.000105	CcSEcCtD
Cefdinir—Diarrhoea—Prednisone—hematologic cancer	3.51e-05	0.000104	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—hematologic cancer	3.5e-05	0.000104	CcSEcCtD
Cefdinir—Nausea—Dexamethasone—hematologic cancer	3.5e-05	0.000104	CcSEcCtD
Cefdinir—Nausea—Betamethasone—hematologic cancer	3.5e-05	0.000104	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—hematologic cancer	3.49e-05	0.000104	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.46e-05	0.000103	CcSEcCtD
Cefdinir—Constipation—Epirubicin—hematologic cancer	3.43e-05	0.000102	CcSEcCtD
Cefdinir—Dizziness—Prednisone—hematologic cancer	3.39e-05	0.000101	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—hematologic cancer	3.39e-05	0.000101	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—hematologic cancer	3.39e-05	0.000101	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—hematologic cancer	3.36e-05	9.96e-05	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—hematologic cancer	3.3e-05	9.79e-05	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—hematologic cancer	3.28e-05	9.74e-05	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—hematologic cancer	3.27e-05	9.7e-05	CcSEcCtD
Cefdinir—Vomiting—Prednisone—hematologic cancer	3.26e-05	9.68e-05	CcSEcCtD
Cefdinir—Rash—Prednisone—hematologic cancer	3.23e-05	9.6e-05	CcSEcCtD
Cefdinir—Dermatitis—Prednisone—hematologic cancer	3.23e-05	9.59e-05	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—hematologic cancer	3.23e-05	9.58e-05	CcSEcCtD
Cefdinir—Headache—Prednisone—hematologic cancer	3.21e-05	9.54e-05	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.2e-05	9.51e-05	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—hematologic cancer	3.17e-05	9.42e-05	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—hematologic cancer	3.17e-05	9.41e-05	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—hematologic cancer	3.17e-05	9.41e-05	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—hematologic cancer	3.16e-05	9.37e-05	CcSEcCtD
Cefdinir—Asthenia—Methotrexate—hematologic cancer	3.08e-05	9.13e-05	CcSEcCtD
Cefdinir—Nausea—Prednisone—hematologic cancer	3.05e-05	9.04e-05	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.03e-05	9.01e-05	CcSEcCtD
Cefdinir—Pruritus—Methotrexate—hematologic cancer	3.03e-05	9e-05	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.03e-05	0.000593	CbGpPWpGaD
Cefdinir—Hypersensitivity—Epirubicin—hematologic cancer	2.96e-05	8.77e-05	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—hematologic cancer	2.93e-05	8.71e-05	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—hematologic cancer	2.93e-05	8.71e-05	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—hematologic cancer	2.93e-05	8.7e-05	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—hematologic cancer	2.88e-05	8.54e-05	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—hematologic cancer	2.84e-05	8.42e-05	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.84e-05	0.000555	CbGpPWpGaD
Cefdinir—Dizziness—Methotrexate—hematologic cancer	2.83e-05	8.41e-05	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.81e-05	0.000551	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.76e-05	0.000542	CbGpPWpGaD
Cefdinir—Diarrhoea—Epirubicin—hematologic cancer	2.74e-05	8.15e-05	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—hematologic cancer	2.73e-05	8.12e-05	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—hematologic cancer	2.73e-05	8.09e-05	CcSEcCtD
Cefdinir—Rash—Methotrexate—hematologic cancer	2.7e-05	8.02e-05	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—hematologic cancer	2.7e-05	8.01e-05	CcSEcCtD
Cefdinir—Headache—Methotrexate—hematologic cancer	2.69e-05	7.97e-05	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—hematologic cancer	2.66e-05	7.9e-05	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—hematologic cancer	2.65e-05	7.87e-05	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.63e-05	0.000515	CbGpPWpGaD
Cefdinir—Pruritus—Doxorubicin—hematologic cancer	2.63e-05	7.79e-05	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	2.59e-05	0.000507	CbGpPWpGaD
Cefdinir—Vomiting—Epirubicin—hematologic cancer	2.55e-05	7.57e-05	CcSEcCtD
Cefdinir—Nausea—Methotrexate—hematologic cancer	2.55e-05	7.56e-05	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—hematologic cancer	2.54e-05	7.54e-05	CcSEcCtD
Cefdinir—Rash—Epirubicin—hematologic cancer	2.53e-05	7.51e-05	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—hematologic cancer	2.53e-05	7.5e-05	CcSEcCtD
Cefdinir—Headache—Epirubicin—hematologic cancer	2.51e-05	7.46e-05	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—hematologic cancer	2.45e-05	7.29e-05	CcSEcCtD
Cefdinir—Nausea—Epirubicin—hematologic cancer	2.38e-05	7.07e-05	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—hematologic cancer	2.36e-05	7e-05	CcSEcCtD
Cefdinir—Rash—Doxorubicin—hematologic cancer	2.34e-05	6.95e-05	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—hematologic cancer	2.34e-05	6.94e-05	CcSEcCtD
Cefdinir—Headache—Doxorubicin—hematologic cancer	2.33e-05	6.9e-05	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—hematologic cancer	2.2e-05	6.54e-05	CcSEcCtD
